ARCHIVES

Women’s Health Was ‘Highest Priority’ Of House Committee

This article is from The Cancer Letter archive.

Vol. 18 No. 31 | July 31, 1992

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976

NCAB Approves, NCI Accepts Powers’ Version Of Board’s Organ Systems Recommendations

May 27, 1983

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989